Arvee Laboratories (India) standalone net profit rises 6.00% in the June 2021 quarter

Arvee Laboratories (India) standalone net profit declines 31.75% in the March 2021 quarter

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Arvee Laboratories provides specialty chemical products. The Company is primarily engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates

Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Ltd

Scorecard

News & Opinions

Arvee Laboratories (India) standalone net profit rises 6.00% in the June 2021 quarter

Arvee Laboratories (India) standalone net profit declines 31.75% in the March 2021 quarter